Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
Nature Chemical Biology
|
August 19, 2020
Structural dissimilarity from self drives neoepitope escape from immune tolerance
Jason R Devlin, Jesus A Alonso, Cory M Ayres, et al.
Molecular Systems Biology
|
April 29, 2011
The multiple-specificity landscape of modular peptide recognition domains
David Gfeller, Frank Butty, Marta Wierzbicka, et al.
Iscience
|
March 23, 2023
Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinity
Hajer Fritah, Michele Graciotti, Cheryl Lai-Lai Chiang, et al.
Science Advances
|
March 5, 2025
Donor HLA-DQ genetic and functional divergence affect the control of BK polyoma virus infection after kidney transplantation
Mathieu F Chevalier, Vincent Allain, Julien Gras, et al.
The Journal of Biological Chemistry
|
June 15, 2012
Sequence determinants of a microtubule tip localization signal (MtLS)
Rubén M Buey, Indrani Sen, Oliver Kortt, et al.
Immunity
|
January 13, 2019
Intratumoral Tcf1<sup>+</sup>PD-1<sup>+</sup>CD8<sup>+</sup> T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy
Imran Siddiqui, Karin Schaeuble, Vijaykumar Chennupati, et al.
Immunity
|
April 6, 2023
Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopes
Julien Racle, Philippe Guillaume, Julien Schmidt, et al.
Journal of Molecular Biology
|
November 25, 2018
Allosteric Modulation of Binding Specificity by Alternative Packing of Protein Cores
Moshe Ben-David, Haiming Huang, Mark G F Sun, et al.
Frontiers in Immunology
|
August 24, 2019
A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three Patients
Michal Bassani-Sternberg, Antonia Digklia, Florian Huber, et al.
The Journal of Clinical Investigation
|
June 27, 2017
ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence
Mathieu F Chevalier, Sara Trabanelli, Julien Racle, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
Nature Chemical Biology
|
August 19, 2020
Structural dissimilarity from self drives neoepitope escape from immune tolerance
Jason R Devlin, Jesus A Alonso, Cory M Ayres, et al.
Molecular Systems Biology
|
April 29, 2011
The multiple-specificity landscape of modular peptide recognition domains
David Gfeller, Frank Butty, Marta Wierzbicka, et al.
Iscience
|
March 23, 2023
Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinity
Hajer Fritah, Michele Graciotti, Cheryl Lai-Lai Chiang, et al.
Science Advances
|
March 5, 2025
Donor HLA-DQ genetic and functional divergence affect the control of BK polyoma virus infection after kidney transplantation
Mathieu F Chevalier, Vincent Allain, Julien Gras, et al.
The Journal of Biological Chemistry
|
June 15, 2012
Sequence determinants of a microtubule tip localization signal (MtLS)
Rubén M Buey, Indrani Sen, Oliver Kortt, et al.
Immunity
|
January 13, 2019
Intratumoral Tcf1<sup>+</sup>PD-1<sup>+</sup>CD8<sup>+</sup> T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy
Imran Siddiqui, Karin Schaeuble, Vijaykumar Chennupati, et al.
Immunity
|
April 6, 2023
Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopes
Julien Racle, Philippe Guillaume, Julien Schmidt, et al.
Journal of Molecular Biology
|
November 25, 2018
Allosteric Modulation of Binding Specificity by Alternative Packing of Protein Cores
Moshe Ben-David, Haiming Huang, Mark G F Sun, et al.
Frontiers in Immunology
|
August 24, 2019
A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three Patients
Michal Bassani-Sternberg, Antonia Digklia, Florian Huber, et al.
The Journal of Clinical Investigation
|
June 27, 2017
ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence
Mathieu F Chevalier, Sara Trabanelli, Julien Racle, et al.
Page
of 9